Haemonetics
HAE
HAE
296 hedge funds and large institutions have $4.55B invested in Haemonetics in 2023 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 97 increasing their positions, 123 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.08% more ownership
Funds ownership: 99.95% → 100.03% (+0.08%)
0% more funds holding
Funds holding: 296 → 296 (0)
21% less repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 123
Holders
296
Holding in Top 10
2
Calls
$18M
Puts
$2.25M
Top Buyers
| 1 | +$75.9M | |
| 2 | +$26.5M | |
| 3 | +$13.5M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$10.7M |
| 5 |
KCM
Kingdon Capital Management
New York
|
+$9.95M |
Top Sellers
| 1 | -$39.1M | |
| 2 | -$37.2M | |
| 3 | -$20.1M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$15.1M |
| 5 |
Man Group
London,
United Kingdom
|
-$7.85M |